US2804460A - Tropene derivatives - Google Patents
Tropene derivatives Download PDFInfo
- Publication number
- US2804460A US2804460A US522393A US52239355A US2804460A US 2804460 A US2804460 A US 2804460A US 522393 A US522393 A US 522393A US 52239355 A US52239355 A US 52239355A US 2804460 A US2804460 A US 2804460A
- Authority
- US
- United States
- Prior art keywords
- grams
- degrees centigrade
- derivatives
- tropene
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
Definitions
- This invention relates to novel organic compounds and is more particularly concerned with certain diquaternary ammonio derivatives of tropane, tropine, and tropine-like materials.
- n is an integer from two to four, inclusive
- R and R1 are lower-alkyl, and wherein said R and R1 may be the same, different or joined together to form an N-heterocyclic group, the sum of the carbon atoms in said Rs and R1 being from three to six, inclusive,
- H H H H H OH, 0, and monocarboxylic acid ester residue and X and X are stable, non-toxic anions.
- the compounds of the present invention are crystalline solids having relatively high melting points and are water soluble. Preliminary pharmacological testing of these compounds has indicated that they have utility as hypotensive agents. A distinct advantage accruing from the use of the present compounds in animals has indicated that a floor-level blood pressure fall is obtained, after certain minimum dosage has been administered. It can be administered at a very high relative dosage without causing untoward effects in both mice and monkeys when compared to presently employed hypotensive agents. Further, after an initial dosage of the compounds of the present invention in animals, the maintenance dosage required to keep the blood pressure at a reduced level is substantially less than would normally be expected. Intravenous administration in an aqueous solution has been the usual method of administration.
- Preparation of the compounds of the present invention may be readily accomplished by providing an appropriate tropane, tropine or tropine-like derivative, and reacting this material with a suitable halodimethylene, trimethylene or tetramethylene quaternary ammonium salt having the following formula:
- n, Rs, R1 and X have the hereinbefore assigned values and X" is a halogen selected from the group consisting of chlorine, bromine and iodine.
- Reaction is normally accomplished by mixing the two reactants in a suitable solvent, such as acetonitrile, alcohols such as ethanol, methanol, isopropyl alcohol, propyl alcohol, isoamyl alcohol, et cetera; nitrobenzene, nitromethane, nitroethane, mixtures of dioxane and an alcohol and other polar solvents and solvent mixtures, et cetera.
- reaction product may be recovered by cooling the reaction mixture and separating the crystals which form. Purification of these crystals is accomplished in conventional manner, as by recrystallization from an appropriate solvent.
- Atropine which is a tropane derivative containing a substituent hydrogen and an alpha-(hydroxymethyl)- phenylacetic acid residue (tropic acid residue) attached to the same carbon atom.
- alkanoic, aromatic and aralkanoic containing up to 15 carbon atoms such as, for example, acetoxy, propionoxy, butyroxy, benzoxy, S-(beta-naphthyl) -valeroxy, 3-dimethylbutyroxy, alpha-naphthalene carboxy, veratroxy, diphenylacetoxy, 9-flu0renecarboxy, phenylacetoxy, etc.
- stable, non-toxic anions as used herein is intended to include those which form stable quaternary salts with the type of materials here employed and which are substantially non-toxic when administered as hypotensive agents.
- Representative anions which are suitable include, for example, the chloride, bromide, iodide, sulfate, nitrate, citrate, lactate, tartrate, tannate, malate, et cetera.
- Example 1 A solution of 33.6 grams (0.25 mole) of tropine and 68.0 grams (0.25 mole) of 3-bromopropyltrimethylammonium bromide in 300 milliliters of acetonitrile was refluxed for 24 hours. An oily precipitate formed which was collected and recrystallized from ethyl alcohol and ethyl acetate. There was thus obtained 63.0 grams (63 percent of the theoretical yield) of l-tropinium-3-(trimethylammonium)-propane dibromide, melting with gas evolution at 247 degrees centigrade.
- Example 2 A solution of 7.7 grams (0.055 mole) of tropine and 16.4 grams (0.055 mole) of 3-bromopropylmethylpiperidinium bromide in milliliters of acetonitrile was refluxed on a steam bath for three hours. At the end of this period, the crystalline product was filtered from the Warm solution and recrystallized twice from a mixture of ethanol and ethyl acetate to yield 5 .15 grams of l-tropinium-3-(N-methylpiperidinium)-propane dibromide, as fine white needles, which darken above 230 degrees centigrade and melt above 270 degrees centigrade.
- Example 3 A solution containing 10.0 grams (0.071 mole) of tropine and 20.4 grams (0.071 mole) of 3-bromopropylmethylpyrrolidiniurn bromide in 100 milliliters of acetonitrile was refluxed on the steam bath for five hours. At the end of this time, the crude crystalline product was filtered from the warm solution and recrystallized twice from ethanol and ethyl acetate to yield 17.2 grams (57 percent of the theoretical yield) of l-tropiniurn-S- (N-methylpyrrolidinium)-propane dibromide, as white crystals which darken at 235 degrees centigrade and decompose at about 268 degrees centigrade.
- Atropine may be reacted with 3-bromopropyltrimethylammonium bromide to yield 1-atropinium-3-(trimethylammonium)-propane dibromide melting at 207 degrees Centigrade.
- Tropinone may be reacted with 3-bromopropyltrimethylammonium bromide to yield l-tropinonium-3-(trimethylammonium)-propa.ne dibromide having a melting 5 invention without departing from the spirit or scope thereof and it is to be understood that we limit us only as defined in the appended claims.
- nH2n I X!- B1 wherein n is an integer from two to four, inclusive, R and R1 represent lower-alkyl radicals which may be joined together to form an N-heterocyclic group, the sum of the carbon atoms in said radicals and group being from three to six, inclusive, A is selected from the group consisting of H H H H OH monocarboxylic acid ester residue and wherein X and X are stable, non-toxic anions.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
United States Patent l 2,804,460 TROPENE DERIVATIVES Chester J. Cavallito, Allan Poe Gray, and Wesley Lea Archer, Decatur, 111., assignors to Irwin, Neisler and Company, Decatur, 111., a corporation of Illinois No Drawing. Application July 15, 1955, Serial No. 522,393
6 Claims. (Cl. 260292) This invention relates to novel organic compounds and is more particularly concerned with certain diquaternary ammonio derivatives of tropane, tropine, and tropine-like materials.
Specifically, the compounds of the present invention wherein n is an integer from two to four, inclusive, R and R1 are lower-alkyl, and wherein said R and R1 may be the same, different or joined together to form an N-heterocyclic group, the sum of the carbon atoms in said Rs and R1 being from three to six, inclusive,
H H H H OH, =0, and monocarboxylic acid ester residue and X and X are stable, non-toxic anions.
The compounds of the present invention are crystalline solids having relatively high melting points and are water soluble. Preliminary pharmacological testing of these compounds has indicated that they have utility as hypotensive agents. A distinct advantage accruing from the use of the present compounds in animals has indicated that a floor-level blood pressure fall is obtained, after certain minimum dosage has been administered. It can be administered at a very high relative dosage without causing untoward effects in both mice and monkeys when compared to presently employed hypotensive agents. Further, after an initial dosage of the compounds of the present invention in animals, the maintenance dosage required to keep the blood pressure at a reduced level is substantially less than would normally be expected. Intravenous administration in an aqueous solution has been the usual method of administration.
Preparation of the compounds of the present invention may be readily accomplished by providing an appropriate tropane, tropine or tropine-like derivative, and reacting this material with a suitable halodimethylene, trimethylene or tetramethylene quaternary ammonium salt having the following formula:
2,804,460 Patented Aug. 27, 1957 wherein n, Rs, R1 and X have the hereinbefore assigned values and X" is a halogen selected from the group consisting of chlorine, bromine and iodine. Reaction is normally accomplished by mixing the two reactants in a suitable solvent, such as acetonitrile, alcohols such as ethanol, methanol, isopropyl alcohol, propyl alcohol, isoamyl alcohol, et cetera; nitrobenzene, nitromethane, nitroethane, mixtures of dioxane and an alcohol and other polar solvents and solvent mixtures, et cetera. Normally, to insure an efficient reaction, a somewhat elevated temperature is employed, however, room temperature to 150 degrees centigrade is satisfactory and areflux temperature of about eighty to ninety degrees centigrade is preferred. Upon completion of the reaction, the reaction product may be recovered by cooling the reaction mixture and separating the crystals which form. Purification of these crystals is accomplished in conventional manner, as by recrystallization from an appropriate solvent.
The starting materials employed in the process of the present invention are well known in the art, and others are described in a copending application of C. J. Cavallito and A. P. Gray, Serial 406,052, filed January 25, 1954. One starting material which is readily available and applicable for preparing compounds of the present invention is atropine, which is a tropane derivative containing a substituent hydrogen and an alpha-(hydroxymethyl)- phenylacetic acid residue (tropic acid residue) attached to the same carbon atom. Other monocarboxylic acid ester residues which are suitable include alkanoic, aromatic and aralkanoic containing up to 15 carbon atoms, such as, for example, acetoxy, propionoxy, butyroxy, benzoxy, S-(beta-naphthyl) -valeroxy, 3-dimethylbutyroxy, alpha-naphthalene carboxy, veratroxy, diphenylacetoxy, 9-flu0renecarboxy, phenylacetoxy, etc. The term stable, non-toxic anions as used herein, is intended to include those which form stable quaternary salts with the type of materials here employed and which are substantially non-toxic when administered as hypotensive agents. Representative anions which are suitable, include, for example, the chloride, bromide, iodide, sulfate, nitrate, citrate, lactate, tartrate, tannate, malate, et cetera.
The following examples are given to illustrate the procedure of the present invention, but are not to be construed as limiting.
Example 1 A solution of 33.6 grams (0.25 mole) of tropine and 68.0 grams (0.25 mole) of 3-bromopropyltrimethylammonium bromide in 300 milliliters of acetonitrile was refluxed for 24 hours. An oily precipitate formed which was collected and recrystallized from ethyl alcohol and ethyl acetate. There was thus obtained 63.0 grams (63 percent of the theoretical yield) of l-tropinium-3-(trimethylammonium)-propane dibromide, melting with gas evolution at 247 degrees centigrade.
Analysis.Calculated: C, 41.80; H, 7.52; Br, 39.74. Found: C, 42.03; H, 7.71; Br, 39.47.
Example 2 A solution of 7.7 grams (0.055 mole) of tropine and 16.4 grams (0.055 mole) of 3-bromopropylmethylpiperidinium bromide in milliliters of acetonitrile was refluxed on a steam bath for three hours. At the end of this period, the crystalline product was filtered from the Warm solution and recrystallized twice from a mixture of ethanol and ethyl acetate to yield 5 .15 grams of l-tropinium-3-(N-methylpiperidinium)-propane dibromide, as fine white needles, which darken above 230 degrees centigrade and melt above 270 degrees centigrade.
Analysis-Calculated: C, 46.16; H, 7.75; Br, 36.14. Found: C, 46.50; H, 7.53; Br, 36.02.
Example 3 .A solution containing 10.0 grams (0.071 mole) of tropine and 20.4 grams (0.071 mole) of 3-bromopropylmethylpyrrolidiniurn bromide in 100 milliliters of acetonitrile was refluxed on the steam bath for five hours. At the end of this time, the crude crystalline product was filtered from the warm solution and recrystallized twice from ethanol and ethyl acetate to yield 17.2 grams (57 percent of the theoretical yield) of l-tropiniurn-S- (N-methylpyrrolidinium)-propane dibromide, as white crystals which darken at 235 degrees centigrade and decompose at about 268 degrees centigrade.
Analysis.Calculated: C, 44.87; H, 7.53; Br, 37.32. Found: C, 44.93; H, 7.23; Br, 36.93. In a manner similar to that of the above examples, 1-tropanium-3- (trimethylammonium)-propane dibromide, melting above 270 degrees centigrade is obtained.
Analysis.-Calculated: C, 43.53; H, 7.83; Br, 41.38. Found: C, 43.3 8;H, 7.95; Br, 41.02.
Atropine may be reacted with 3-bromopropyltrimethylammonium bromide to yield 1-atropinium-3-(trimethylammonium)-propane dibromide melting at 207 degrees Centigrade.
Analysis.Calculated: C, 50.18; H, 6.96; Br, 29.04. Found: C, 50.36; H, 7.03; Br, 29.22.
Tropinone may be reacted with 3-bromopropyltrimethylammonium bromide to yield l-tropinonium-3-(trimethylammonium)-propa.ne dibromide having a melting 5 invention without departing from the spirit or scope thereof and it is to be understood that we limit ourselves only as defined in the appended claims.
We claim:
1. A compound having the formula:
H H20 C CH:
+C Hz N C A 1\ l H: C H:
I nH2n I X!- B1 wherein n is an integer from two to four, inclusive, R and R1 represent lower-alkyl radicals which may be joined together to form an N-heterocyclic group, the sum of the carbon atoms in said radicals and group being from three to six, inclusive, A is selected from the group consisting of H H H H OH monocarboxylic acid ester residue and wherein X and X are stable, non-toxic anions.
2. 1-tropinium-3-(trimethylammonium)propane dibromide.
3. 1-tropinium-3-(N-methylpyrrolidinium)-propane dibromide.
4. 1-tropanium-3-(trimethylammonium)-propane dibromide.
5. 1-atropinium-3-(trirnetliylammonium)-propane dibromide.
6. 1-tropinonium-3-(trimethylamrnonium)-propane dibromide.
No references cited.
Claims (1)
1.A COMPOUND HAVING THE FORMULA: WHEREIN N IS AN INTEGER FROM TWO TO FOUR, INCLUSIVE, R AND R1 REPRESENT LOWER-ALKYL RADICALS WHICH MAY BE JOINED TOGETHER TO FORM AN N-HETTEROCYCLIC GROUP, THE SUM OF THE CARBON ATOMS IN SAID RADICALS AND GROUP BEING FROM THREE TO SIX, INCLUSIVE, <A IS SELECTED FROM THE GROUP CONSISTING OF.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US522393A US2804460A (en) | 1955-07-15 | 1955-07-15 | Tropene derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US522393A US2804460A (en) | 1955-07-15 | 1955-07-15 | Tropene derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
US2804460A true US2804460A (en) | 1957-08-27 |
Family
ID=24080682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US522393A Expired - Lifetime US2804460A (en) | 1955-07-15 | 1955-07-15 | Tropene derivatives |
Country Status (1)
Country | Link |
---|---|
US (1) | US2804460A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2927111A (en) * | 1958-02-14 | 1960-03-01 | Lakeside Lab Inc | Tropyl hydrazines |
US2970144A (en) * | 1957-12-11 | 1961-01-31 | Smith Kline French Lab | Esters of 9-alkyl-3-oxa and 3-thia-9-azabicyclo [3. 3. 1]-nonan-7-ol |
US5045546A (en) * | 1990-10-26 | 1991-09-03 | Hoechst-Roussel Pharmaceuticals Inc. | 8-azabicyclo[3.2.1]octylalkylthiazolidines |
-
1955
- 1955-07-15 US US522393A patent/US2804460A/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
None * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2970144A (en) * | 1957-12-11 | 1961-01-31 | Smith Kline French Lab | Esters of 9-alkyl-3-oxa and 3-thia-9-azabicyclo [3. 3. 1]-nonan-7-ol |
US2927111A (en) * | 1958-02-14 | 1960-03-01 | Lakeside Lab Inc | Tropyl hydrazines |
US5045546A (en) * | 1990-10-26 | 1991-09-03 | Hoechst-Roussel Pharmaceuticals Inc. | 8-azabicyclo[3.2.1]octylalkylthiazolidines |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3480626A (en) | Certain azoniaspironortropine derivatives | |
US2692285A (en) | Di-sec-alkyl-dialkylammonium salts and processes for preparing the same | |
US2804460A (en) | Tropene derivatives | |
AU2019231721B2 (en) | Process for preparing soluble guanylate cyclase stimulators | |
US3903164A (en) | Pharmacodynamically active amino alkyloxim ethers | |
US2811527A (en) | Derivatives of thieno (3, 2-b) pyridine and method of preparing same | |
US3198802A (en) | Ethyl 4-phenyl-1-(1-pyrenylmethyl) piperidine-4-carboxylate | |
DK161646B (en) | PROCEDURE FOR THE PREPARATION OF ERGOLINE DERIVATIVES AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF | |
US3321484A (en) | Pyridinecarboxylic acid esters of cyclobutanediols | |
US2657231A (en) | Process for producing alkylene-bis-dithio-alkylene and -arylene-dicarboxylic acids | |
US2776299A (en) | Quaternary ammonium salts of dialkylaminoalkyl esters of thiaxanthene-10-carboxylic acid | |
US2743270A (en) | Heterocyclic nitrogen compounds | |
US2759943A (en) | Derivatives of 2-n-methyl-1, 2, 3, 4-tetrahydro-gamma-carbolines | |
US2461950A (en) | or x-amino quinazolines | |
US2655506A (en) | Pyrazole compounds | |
US2910505A (en) | S-substituted n-benzhydryl pseudothioureas and their pseudothiouronium salts | |
US2762804A (en) | 3-methyl-5-phenyl-2, 6-piperazinedione and derivatives thereof and method of preparing same | |
US3337569A (en) | Method of producing o-nicotinoylcholine chloride | |
US2704284A (en) | Therapeutic compounds | |
US2673873A (en) | Basic esters of 9, 10-dihalogenated 9, 10-dihydro-9, 10-ethanoanthracene-11-carboxylic acids and their derivatives | |
US3198794A (en) | Pyrenylmethyl quaternary ammonium salts | |
US2752385A (en) | Quaternary ammonium salts of alkyl (hydroxyalkyl) aminoalkyl benzilates and esters thereof | |
US3118905A (en) | N-(haloalkyl)-endo-perhydro-4, 7-methanoisoindoles | |
US2741614A (en) | N-isobutylnormorpfflne compounds | |
US2748121A (en) | 6-nitroaryl derivatives of 2-amino-4-pyrimidols |